Eight principles for safer opioid prescribing and cautions with benzodiazepines

References

• Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657–9.
   PubMed Web of Science ®Google Scholar
• Dasgupta N. Opioid analgesic prescribing and overdose mortality in North Carolina [dissertation]. Chapel Hill, NC: University of North Carolina at Chapel Hill; 2013.
   Google Scholar
• King SA, Strain JJ. Benzodiazepine use by chronic pain patients. Clin J Pain 1990;6:143–7.
   PubMed Web of Science ®Google Scholar
• Deyo RA, Smith DHM, Johnson ES, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med 2011;24:717–27.
   PubMed Web of Science ®Google Scholar
• Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170:1425–32.
   PubMedGoogle Scholar
• Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic noncancer pain. Pain Physician 2009;12:259–67.
   PubMed Web of Science ®Google Scholar
• Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46.
   PubMed Web of Science ®Google Scholar
• Hojsted J, Ekholm O, Kurita GP, et al. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain 2013;154:2677–83.
   PubMedGoogle Scholar
• Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain 2009;145:287–92.
   PubMed Web of Science ®Google Scholar
• Kao MC, Zheng P, Mackey S. Trends in benzodiazepine prescription and co-prescription with opioids in the United States, 2002 to 2009. Poster presented at the 30th Annual Meeting of the American Academy of Pain Medicine, March 2014, Phoenix, AZ.
   Google Scholar
• Khong TP, de Vries F, Goldenberg JS, et al. Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States. Calcif Tissue Int 2012;91:24–31.
   PubMedGoogle Scholar
• Nurminen J, Puustinen J, Piirtola M, et al. Opioids, antiepileptic and anticholinergic drugs and the risk of fractures in patients 65 years of age and older: a prospective population-based study. Age Ageing 2013;42:318–24.
   PubMedGoogle Scholar
• Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613–20.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN report: emergency department visits involving nonmedical use of the anti-anxiety medication alprazolam. Rockville, MD: 2014.
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The TEDS report: admissions reporting benzodiazepine and narcotic pain reliever abuse at treatment entry. Rockville, MD: 2012.
   Google Scholar
• Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs — United States, 2004–2007. MMWR Morb Mortal Wkly Rep 2010;59:705–9.
   PubMedGoogle Scholar
• Fine PG, Dasgupta N, Webster LR. Deaths related to opioids prescribed for chronic pain: causes and solutions. Supplement editors. Pain Med 2011;12:S13–92.
   PubMedGoogle Scholar
• Nuckols TK, Anderson L, Popescu I. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38–47.
   PubMed Web of Science ®Google Scholar
• Schatman ME. Interdisciplinary chronic pain management: international perspectives. Pain. 2012. 20(7). Website of the International Association for the Study of Pain www.iasp-pain.org. Accessed 11 June 2014.
   Google Scholar
• Schatman ME. The role of the health insurance industry in perpetuating suboptimal pain management. Pain Med 2011;12:415–26.
   PubMed Web of Science ®Google Scholar
• Webster LR. Eight principles for safer opioid prescribing. Pain Med 2013;14:959–61.
   PubMedGoogle Scholar
• Reisfield GM, Webster LR. Benzodiazepines in long-term opioid therapy. Pain Med 2013;14:1441–6.
   PubMed Web of Science ®Google Scholar
• Website of the LifeSource Foundation. Physician education: 8 prescribing guidelines. yourlife-source.org. Accessed 9 June 2014.
   Google Scholar
• Cochella S, Bateman K. Provider detailing: an intervention to decrease prescription opioid deaths in Utah. Pain Med 2011;12:S73–6.
   PubMedGoogle Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: validation of the opioid risk tool. Pain Med 2005;6:432–42.
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65–75.
   PubMed Web of Science ®Google Scholar
• Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain 2006;7:671–81.
   PubMed Web of Science ®Google Scholar
• Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med 2003;4:182–5.
   PubMed Web of Science ®Google Scholar
• Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002;18:28–38.
   PubMed Web of Science ®Google Scholar
• Dunbar SA, Katz NP. Chronic opioid therapy for non-malignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage 1996;11:163–71.
   PubMed Web of Science ®Google Scholar
• Passik SD, Kirsh KL, Whitcomb L, et al. Monitoring outcomes during long-term opioid therapy for noncancer pain: results with the Pain Assessment and Documentation Tool. J Opioid Manag 2005;1:257–66.
   PubMedGoogle Scholar
• Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain 2007;130:144–56.
   PubMed Web of Science ®Google Scholar
• Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107–12.
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Schatzberg AF. Chronic pain and major depressive disorder in the general population. J Psychiatr Res 2010;44:454–61.
   PubMed Web of Science ®Google Scholar
• Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry 2010;71:491–6.
   PubMed Web of Science ®Google Scholar
• Wasan AD, Butler SF, Budman SH, et al. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007;23:307–15.
   PubMed Web of Science ®Google Scholar
• Knotkova H, Fine PG, Portenoy RK. Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage 2009;38:426–39; Review.
   PubMed Web of Science ®Google Scholar
• Webster LR, Fine PG. Review and critique of opioid rotation practices and associated risks of toxicity. Pain Med 2012;13:562–70.
   PubMed Web of Science ®Google Scholar
• Webster LR, Fine PG. Overdose deaths demand a new paradigm for opioid rotation. Pain Med 2012;13:571–4.
   PubMed Web of Science ®Google Scholar
• Webster LR, Choi Y, Desai H, Grant BJB, Webster L. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008;9:425–32.
   PubMed Web of Science ®Google Scholar
• Mikolaenko I, Robinson CAJr, Davis GG. A review of methadone deaths in Jefferson County, Alabama. Am J Forensic Med Pathol 2002;23:299–304.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Information for healthcare professionals: methadone hydrochloride. Silver Spring, MD: US Department of Health and Human Services; 2006.
   Google Scholar
• Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002;41:1153–93.
   PubMed Web of Science ®Google Scholar
• Webster LR. Methadone-related deaths. J Opioid Manag 2005;1:211–17.
   PubMedGoogle Scholar
• Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest 2005;128:1348–56.
   PubMed Web of Science ®Google Scholar
• Rich BA, Webster LR. A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose. Pain Med 2011;12:S59–65.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA public health advisory: important information for the safe use of fentanyl transdermal system (patch). Silver Spring, MD: US Department of Health and Human Services; 2007.
   Google Scholar
• Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry 2013;28:7–20.
   PubMed Web of Science ®Google Scholar